2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide

C18H26N4O3 — CID 51075038

IUPAC2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide
SMILESNC(=O)C(c1ccccc1)N1CCN(C(=O)CN2CCOCC2)CC1
InChIInChI=1S/C18H26N4O3/c19-18(24)17(15-4-2-1-3-5-15)22-8-6-21(7-9-22)16(23)14-20-10-12-25-13-11-20/h1-5,17H,6-14H2,(H2,19,24)
InChIKeyRKKFAXDTPFOMST-UHFFFAOYSA-N
MW346.43 g/mol
LogP-0.31
Rot. Bonds5

About 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide

2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide (PubChem CID 51075038) has the molecular formula C18H26N4O3 and a molecular weight of 346.43 g/mol. Its IUPAC name is 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide.

Molecular Properties

Compound Name2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide
PubChem CID51075038
Molecular FormulaC18H26N4O3
Molecular Weight346.43 g/mol
Exact Mass346.20
IUPAC Name2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide
SMILESNC(=O)C(c1ccccc1)N1CCN(C(=O)CN2CCOCC2)CC1
InChIInChI=1S/C18H26N4O3/c19-18(24)17(15-4-2-1-3-5-15)22-8-6-21(7-9-22)16(23)14-20-10-12-25-13-11-20/h1-5,17H,6-14H2,(H2,19,24)
InChIKeyRKKFAXDTPFOMST-UHFFFAOYSA-N
XLogP-0.31
TPSA79.11 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms25
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500346.43
LogP ≤ 5-0.31
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(2S)-2-(4-fluorophenyl)-2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]acetamide
CID 26040439
N,N-diethyl-2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide
CID 55498439
2-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-2-phenyl-1-piperidin-1-ylethanone
CID 55412944
3-amino-1-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-3-phenylpropan-1-one
CID 119952905
(2S)-N-(3-acetylphenyl)-2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide
CID 30172697
3-amino-2-methyl-1-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-3-phenylpropan-1-one
CID 119840042
(2S)-N-(4-methylphenyl)-2-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-2-phenylacetamide
CID 30735407
(2R)-2-(4-acetylpiperazin-1-yl)-2-phenylacetamide
CID 51908871
2-[4-(2-hydroxy-2-phenylethyl)piperazin-1-yl]-1-morpholin-4-ylethanone
CID 56827835
(2R)-N-(3-chloro-4-methylphenyl)-2-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-2-phenylacetamide
CID 30628130
2-(4-ethylpiperazin-1-yl)-2-phenylacetamide
CID 86915510
(2R)-N-(2-ethoxyphenyl)-2-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-2-phenylacetamide
CID 30629328

Frequently Asked Questions

What is the IUPAC name of 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide?
The IUPAC name of 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide (CID 51075038) is 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide.
What is the SMILES notation for 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide?
The canonical SMILES for 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide is NC(=O)C(c1ccccc1)N1CCN(C(=O)CN2CCOCC2)CC1.
What is the InChIKey of 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide?
The InChIKey is RKKFAXDTPFOMST-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H26N4O3/c19-18(24)17(15-4-2-1-3-5-15)22-8-6-21(7-9-22)16(23)14-20-10-12-25-13-11-20/h1-5,17H,6-14H2,(H2,19,24).
What are the key properties of 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide?
2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide has a molecular weight of 346.43 g/mol, XLogP of -0.31, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(2-morpholin-4-ylacetyl)piperazin-1-yl]-2-phenylacetamide is sourced from PubChem (CID 51075038), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).